Annual Report 2009

Message from our CEO

In 2009, Crucell’s vaccines were administered to a vast number of people worldwide...

Performance highlights

2009 proved to be a year of record revenues and profits for Crucell...

Our business

Crucell vaccines have an excellent safety record and are distributed globally in more...

Our commitment to CSR

As part of Crucell’s corporate strategy, The Crucell Ambition, we are working hard to...

Management report

This section is available to download as a series of pdf documents...

• Overview
• 2009 key highlights
• Crucell at a glance
• Crucell: a global perspective
• Performance highlights
• Message from our CEO
• The Crucell Ambition
• Management Committee
• Report of the Supervisory Board

• Our Business
• Research & development, technologies and products
• Research & development
• Technologies
• Products

• Crucell's commitment to CSR
• Expanding the scope of our ambitions
• Crucell's responsibility to society
• Transparency: Developing our approach to CSR
  • Crucell and the Global Reporting Initiative 2009
• Review: Crucell's contribution to society in 2009
  • 4P Framework: Performance
  • 4P Framework: People
  • 4P Framework: Planet
  • 4P Framework: Philanthropy
• The way forward: Our CSR ambitions, targets and tools